Hagerling, C., Owyong, M., Sitarama, V., Wang, C., Lin, C., van den Bijgaart, R. J. E., . . . UMC, H. I. w. (2020). LGR5 in breast cancer and ductal carcinoma in situ: A diagnostic and prognostic biomarker and a therapeutic target.
Chicago Style (17th ed.) CitationHagerling, Catharina, et al. LGR5 in Breast Cancer and Ductal Carcinoma in Situ: A Diagnostic and Prognostic Biomarker and a Therapeutic Target. 2020.
MLA (9th ed.) CitationHagerling, Catharina, et al. LGR5 in Breast Cancer and Ductal Carcinoma in Situ: A Diagnostic and Prognostic Biomarker and a Therapeutic Target. 2020.
Warning: These citations may not always be 100% accurate.